It's Not All About the Cardiomyocyte: Fibroblasts, Empagliflozin, and Cardiac Remodelling

Can J Cardiol. 2020 Apr;36(4):464-466. doi: 10.1016/j.cjca.2019.10.017. Epub 2019 Oct 19.

Authors

Patrick Meagher¹, Mohamed Adam¹, Kim Connelly²

Affiliations

¹ Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
² Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada. Electronic address: connellyk@smh.ca.

PMID: 32107088
DOI: 10.1016/j.cjca.2019.10.017

No abstract available

Publication types

Editorial
Comment

MeSH terms

Benzhydryl Compounds
Diabetes Mellitus, Type 2*
Extracellular Matrix
Fibroblasts
Glucosides
Humans
Myocytes, Cardiac*
Myofibroblasts
Ventricular Remodeling

Substances

Benzhydryl Compounds
Glucosides
empagliflozin